1. Home
  2. FEMY vs NWGL Comparison

FEMY vs NWGL Comparison

Compare FEMY & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • NWGL
  • Stock Information
  • Founded
  • FEMY 2004
  • NWGL 2008
  • Country
  • FEMY United States
  • NWGL Macau
  • Employees
  • FEMY N/A
  • NWGL N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • NWGL
  • Sector
  • FEMY Health Care
  • NWGL
  • Exchange
  • FEMY Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • FEMY 31.9M
  • NWGL 26.2M
  • IPO Year
  • FEMY 2021
  • NWGL 2023
  • Fundamental
  • Price
  • FEMY $0.95
  • NWGL $1.04
  • Analyst Decision
  • FEMY Strong Buy
  • NWGL
  • Analyst Count
  • FEMY 3
  • NWGL 0
  • Target Price
  • FEMY $8.67
  • NWGL N/A
  • AVG Volume (30 Days)
  • FEMY 361.1K
  • NWGL 790.9K
  • Earning Date
  • FEMY 08-07-2025
  • NWGL 07-22-2025
  • Dividend Yield
  • FEMY N/A
  • NWGL N/A
  • EPS Growth
  • FEMY N/A
  • NWGL N/A
  • EPS
  • FEMY N/A
  • NWGL N/A
  • Revenue
  • FEMY $1,699,232.00
  • NWGL $21,539,347.00
  • Revenue This Year
  • FEMY $231.84
  • NWGL N/A
  • Revenue Next Year
  • FEMY $245.28
  • NWGL N/A
  • P/E Ratio
  • FEMY N/A
  • NWGL N/A
  • Revenue Growth
  • FEMY 61.97
  • NWGL N/A
  • 52 Week Low
  • FEMY $0.69
  • NWGL $0.91
  • 52 Week High
  • FEMY $1.80
  • NWGL $6.61
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 50.88
  • NWGL 45.06
  • Support Level
  • FEMY $0.90
  • NWGL $1.02
  • Resistance Level
  • FEMY $0.99
  • NWGL $1.21
  • Average True Range (ATR)
  • FEMY 0.07
  • NWGL 0.20
  • MACD
  • FEMY 0.01
  • NWGL -0.06
  • Stochastic Oscillator
  • FEMY 39.48
  • NWGL 7.93

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: